Search research articles
Contact Us
Filters
Showing results (251-260 of 322) with videos related to
Page
of 33
Sort By:
Cell Reports
|
August 3, 2016
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
Kimberly A Dowd, Christina R DeMaso, Rebecca S Pelc, et al.
Antimicrobial Agents and Chemotherapy
|
February 7, 2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004
D R Snydman, N V Jacobus, L A McDermott, et al.
Scientific Reports
|
March 7, 2017
Citizen science shows systematic changes in the temperature difference between air and inland waters with global warming
Gesa A Weyhenmeyer, Murray Mackay, Jason D Stockwell, et al.
Plos Pathogens
|
May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
Pankaj Pal, Kimberly A Dowd, James D Brien, et al.
The Journal of Investigative Dermatology
|
February 11, 2011
Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated
Julia S Pettersen, Judilyn Fuentes-Duculan, Mayte Suárez-Fariñas, et al.
NPJ Vaccines
|
April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
Mbio
|
December 5, 2019
Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance
Carol L Vinton, Samuel J Magaziner, Kimberly A Dowd, et al.
The Journal of Infectious Diseases
|
May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans
Katherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.
The Journal of Infectious Diseases
|
March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial
Julie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Plos One
|
December 11, 2012
Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β
Pamela Aubert, Mayte Suárez-Fariñas, Hiroshi Mitsui, et al.
Page
of 33
Search research articles
Search
Showing results (251-260 of 322) with videos related to
Sort By:
Page
of 33
Cell Reports
|
August 3, 2016
Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype
Kimberly A Dowd, Christina R DeMaso, Rebecca S Pelc, et al.
Antimicrobial Agents and Chemotherapy
|
February 7, 2007
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004
D R Snydman, N V Jacobus, L A McDermott, et al.
Scientific Reports
|
March 7, 2017
Citizen science shows systematic changes in the temperature difference between air and inland waters with global warming
Gesa A Weyhenmeyer, Murray Mackay, Jason D Stockwell, et al.
Plos Pathogens
|
May 3, 2013
Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus
Pankaj Pal, Kimberly A Dowd, James D Brien, et al.
The Journal of Investigative Dermatology
|
February 11, 2011
Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated
Julia S Pettersen, Judilyn Fuentes-Duculan, Mayte Suárez-Fariñas, et al.
NPJ Vaccines
|
April 20, 2023
An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection
Brooke Bollman, Naveen Nunna, Kapil Bahl, et al.
Mbio
|
December 5, 2019
Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance
Carol L Vinton, Samuel J Magaziner, Kimberly A Dowd, et al.
The Journal of Infectious Diseases
|
May 7, 2021
Limited Flavivirus Cross-Reactive Antibody Responses Elicited by a Zika Virus Deoxyribonucleic Acid Vaccine Candidate in Humans
Katherine E Burgomaster, Bryant M Foreman, Maya A Aleshnick, et al.
The Journal of Infectious Diseases
|
March 15, 2011
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial
Julie E Ledgerwood, Theodore C Pierson, Sarah A Hubka, et al.
Plos One
|
December 11, 2012
Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β
Pamela Aubert, Mayte Suárez-Fariñas, Hiroshi Mitsui, et al.
Page
of 33